EDUCATION > Educational Programs > E-Learning > Videos/Webcasts > 2013 Annual Meeting Webcasts > Prostate Cancer > Module 5: Detection of Prostate Cancer & Castration-Resistant Prostate Cancer: AUA Guidelines

Module 5: Detection of Prostate Cancer & Castration-Resistant Prostate Cancer: AUA Guidelines

Introduction/Activity Overview Statement of Need

This course will review the new AUA guidelines on the detection of prostate cancer and castration-resistant prostate cancer. Faculty will explore the rigorous process used in the development of these evidence-based guidelines, as well as discussing future research needs. The course will showcase clinical scenarios in urological practice and the correct application of the new AUA guidelines in those instances. This course will be a benefit to practicing urologists, non-physician providers, residents preparing for their certification exam, and physicians preparing for their re-certification exam.

Learning Objectives

After participating in this activity, participants should be able to:

  • analyze the latest evidence on the detection of prostate cancer and castration-resistant prostate cancer as outlined in the AUA guidelines
  • improve diagnostic and therapeutic decision-making processes by illustrating the application of these guidelines in urologic practice
  • acquire in-depth knowledge on the process by which evidence is used to develop scientifically rigorous, yet actionable, guidelines

Faculty/Authors Disclosures

Peter C. Albertsen, MD, Faculty
Urologist
Univ of Connecticut Health Center
Farmington, CT

Adam S. Kibel, MD, Faculty
Chairman
Brigham and Women's Hospital
Boston, MA

Bruce J. Roth, MD, Faculty
Professor of Medicine
Division of Oncology
Siteman Cancer Center, Washington university in St. Louis, Missouri

H. Ballentine Carter, MD, Co-Director
Professor of Urology/Oncology
Johns Hopkins School of Medicine
Baltimore, MD

Michael S. Cookson, MD, Co-Director
Rodes and Patricia Hart Professor of Urologic Surg
Vanderbilt University
Nashville, TN

Name

Company

Relationship

Financial

Peter C. Albertsen, MD National Cancer Inst. Consultant or Advisor, Meeting Participant or Lecturer Yes
       
H. Ballentine Carter, MD Nothing to Disclose    
       
Michael S. Cookson, MD Photocure Meeting Participant or Lecturer Yes
       
Adam S. Kibel, MD Dendreon Consultant or Advisor, Meeting Participant or Lecturer Yes
       
Bruce J. Roth, MD Oncogenix Scientific Study or Trial No
       

Acknowledgement for Support

Support provided by educational grants from the following companies:

Abbvir Algeta AMGEN Astellas
Bayer Janseen Medivation Millennium

Michael S. Cookson, MD
Adam S. Kibel, MD
Bruce J. Roth, MD
Castration-Resistant Prostate Cancer (CRPC): AUA Guideline

Part 1:

Part 2:

ADVERTISEMENT

ADVERTISEMENT
Donate
Contact
Press/Media
Sections
Term of Use
Site Map


ADVERTISEMENT